Showing Spotlights 33 - 40 of 134 in category Risks, Toxicology, Biocompatibility (newest first):
There is a growing body of research on using carbon nanotubes (CNTs) and other nanomaterials in neural engineering. Scientists are already exploring the feasibility of using CNTs to probe neural activity. With this research comes the need to develop a unified approach when assessing the toxicity of CNT in neurons. However, a complex picture emerges from the reported data: is it feasible to develop CNT-based devices as drug delivery vectors? Ultimately, are soluble CNT neurotoxic, and, if yes, to what degree? Given the often conflicting results of research reports on the biocompatibility of soluble CNT when administered to neurons in the central nervous system, a review article helps to clarify which aspects (technical or methodological) of these studies may be responsible for their heterogeneous conclusions.
Jul 14th, 2011
Blood platelets are the structural and chemical foundation of blood clotting and they play a vital role in minor injuries when coagulation prevents the loss of blood at the injury site. If the proper function of these platelets gets disturbed, blood clotting can lead to thrombosis, which is a leading cause of death and disability in the developed world. In view of the rapid development of nanotechnology, the impact of the newly engineered nanomaterials as an additional thrombosis risk factor is not yet known but should not be underestimated. In fact, it has been reported that carbon nanotubes induce platelet aggregation and potentiate arterial thrombosis in animal model. However, a mechanism of thrombogenic effects of carbon nanotubes was not known. Researchers have now shown that show the molecular mechanism of carbon nanotubes' induced platelets activation.
Jul 7th, 2011
Engineered nanomaterials present regulators with a conundrum - there is a gut feeling that these materials present a new regulatory challenge, yet the nature and resolution of this challenge remains elusive. But as the debate over the regulation of nanomaterials continues, there are worrying signs that discussions are being driven less by the science of how these materials might cause harm, and more by the politics of confusion and uncertainty. Yet the more we learn about how materials interact with biology, the less clear it becomes where the boundaries of this class of materials called "nanomaterials" lie, or even whether this is a legitimate class of material at all from a regulatory perspective.
Apr 15th, 2011
Life cycle assessment is an essential tool for ensuring the safe, responsible, and sustainable commercialization of a new technology. With missing data about the large scale impact of nanotechnology, life cycle assessments of potential nanoproducts should form an integral part of nanotechnology research at early stages of decision making as it can help in the screening of different process alternatives. Part of any meaningful results from a life cycle assessment is the total quantity of the material under investigation. Especially exposure assessments often begin with estimates based on total amounts of a material produced with the assumption that some fraction of the material in question will ultimately released to the environment. As it turns out, nobody - no research institution, no government agency, no industry association - knows even vaguely how much nanomaterials are manufactured today.
Apr 11th, 2011
At the core of research efforts to determine the impact of synthetic nanoparticles on the environment and living systems is a fundamental understanding of the interactions between man-made nanoparticles and natural living systems that have evolved over millions of years. To describe nanoparticles at large, it may be beneficial to acknowledge that 1) biological systems are part of the food chain and therefore an essential component of the ecosystems and 2) collaborations are essential for such interdisciplinary research. Researchers have now presented a biophysical perspective that describes the fate of nanoparticles in both the aqueous phase and in living systems.
Mar 16th, 2011
Owing to their large surface area, strong infrared photoluminescence and magnetic properties, nanodiamonds are promising for various biomedical applications, including as drug/gene carriers and alternatives to the current bio-imaging platforms. However, the biomedical applications will hardly be realized unless the potential hazards of nanodiamonds to humans and other biological systems are ascertained. The biocompatibility of nanodiamonds at the cellular level has been confirmed by many independent studies. Following these earlier cytotoxicity studies, many groups have used nanodiamonds and their functionalized derivatives for drug/gene deliveries. In spite of the earlier reports that nanodiamonds are biocompatible at the cellular level, researchers have now demonstrated in a new study that nanodiamonds can activate DNA repair proteins in embryonic stem cells, suggesting possible DNA damages.
Mar 10th, 2011
There is a need for the larger nanotechnology community synthesizing, applying or characterizing nanomaterials to have a methodology to evaluate the risk and to apply adequate protection measures to limit human exposure. Researchers in Switzerland have now taken the initiative and presented a practical, user-friendly procedure for a university-wide safety and health management of nanomaterials, developed as a multi-stakeholder effort (government, accident insurance, researchers and experts for occupational safety and health). The procedure consists of two parts: Using a decision tree, nano-labs are sorted into three hazard classes, which corresponds to analogue approaches applied to other hazard types (biohazard, radioprotection or chemistry). A list of required prevention/protection measures (safety barriers) for each hazard level is then provided.
Feb 14th, 2011
The toxicity issues surrounding carbon nanotubes (CNTs) are highly relevant for two reasons: Firstly, as more and more products containing CNTs come to market, there is a chance that free CNTs get released during their life cycles, most likely during production or disposal, and find their way through the environment into the body. Secondly, and much more pertinent with regard to potential health risks, is the use of CNTs in biological and medical settings. Some groups are using CNTs in research for vaccination as well as gene and cancer therapy. Here, the CNT applications are designed to interact directly with the immune system. Understanding the interplay between CNTs and immune proteins is therefore critical for both improving CNT applications in biology and medicine and avoiding potentially noxious immune responses.
Jan 13th, 2011